We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-16.97%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.02B
AUM Growth
-$307M
Cap. Flow
-$225M
Cap. Flow %
-2.49%
Top 10 Hldgs %
20.75%
Holding
813
New
30
Increased
168
Reduced
3
Closed
20

Top Buys

Rank Stock Value
1
HLT icon
Hilton Worldwide
HLT
+$11.3M
2
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$2.97M
3
IVZ icon
Invesco
IVZ
+$1.15M
4
MSFT icon
Microsoft
MSFT
+$13.8K
5
AAPL icon
Apple
AAPL
+$12.4K

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$13.3M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$12.5M
3
INST
Instructure, Inc.
INST
+$9.03M
4
DERM
Dermira, Inc.
DERM
+$8.64M
5
EQH icon
Equitable Holdings
EQH
+$7.36M

Sector Composition

Rank Sector Weight
1 Healthcare 30.92%
2 Technology 19.71%
3 Financials 10.21%
4 Consumer Discretionary 9.38%
5 Communication Services 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XP icon
351
XP
XP
$8.81B
$4.67M 0.05%
124,000
– –
ALLK
352
DELISTED
Allakos
ALLK
$4.66M 0.05%
50,000
– –
NSC icon
353
Norfolk Southern
NSC
$75.4B
$4.66M 0.05%
24,559
– –
NOW icon
354
ServiceNow
NOW
$115B
$4.63M 0.05%
83,815
– –
EIX icon
355
Edison International
EIX
$28.2B
$4.62M 0.05%
62,638
– –
UHS icon
356
Universal Health Services
UHS
$10.2B
$4.62M 0.05%
32,919
– –
WCN
357
Waste Connections
WCN
$42.2B
$4.61M 0.05%
51,967
+16
+0% +$1.5K
KGC icon
358
Kinross Gold
KGC
$27.4B
$4.59M 0.05%
989,618
– –
WELL icon
359
Welltower
WELL
$169B
$4.57M 0.05%
57,201
– –
CNP icon
360
CenterPoint Energy
CNP
$27.7B
$4.57M 0.05%
171,372
– –
RARX
361
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$4.57M 0.05%
99,523
– –
LRCX icon
362
Lam Research
LRCX
$367B
$4.54M 0.05%
158,800
– –
ROST icon
363
Ross Stores
ROST
$80.5B
$4.54M 0.05%
39,864
– –
BLD
364
DELISTED
TopBuild
BLD
$4.5M 0.05%
44,635
+20
+0% +$2.04K
EWC icon
365
iShares MSCI Canada ETF
EWC
$6.13B
$4.5M 0.05%
153,861
– –
BSX icon
366
Boston Scientific
BSX
$69.5B
$4.49M 0.05%
101,553
– –
YUMC icon
367
Yum China
YUMC
$16.5B
$4.48M 0.05%
95,470
– –
SUPN icon
368
Supernus Pharmaceuticals
SUPN
$2.59B
$4.47M 0.05%
193,000
– –
VCYT icon
369
Veracyte
VCYT
$3.7B
$4.46M 0.05%
163,424
+33
+0% +$831
ICE icon
370
Intercontinental Exchange
ICE
$85.6B
$4.45M 0.05%
49,165
– –
FDX icon
371
FedEx
FDX
$72.7B
$4.43M 0.05%
29,995
– –
GH icon
372
Guardant Health
GH
$21.7B
$4.41M 0.05%
57,758
+6
+0% +$460
BWA icon
373
BorgWarner
BWA
$13.1B
$4.38M 0.05%
117,245
– –
NGM
374
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$4.37M 0.05%
242,000
– –
DOW icon
375
Dow Inc
DOW
$21.9B
$4.37M 0.05%
81,702
– –
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q1 2020 Portfolio in Review

As of Q1 2020, Candriam SCA held 813 positions worth $9.02B, down 3.3% from $9.33B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2020 filing shows 30 new, 168 increased, 3 reduced and 20 closed positions. Its largest new stake was Hilton Worldwide: 116,476 shares worth $21.1M. The largest sale was Medicines Co, an estimated $13.3M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2020 buy was Hilton Worldwide: 116,476 shares worth $21.1M.
  • Candriam SCA added most to Microsoft in Q1 2020, an estimated $13.8K increase.
  • Candriam SCA's biggest Q1 2020 reduction was Telus, cutting an estimated $1.67M.
  • Candriam SCA fully exited Medicines Co in Q1 2020, selling an estimated $13.3M.
  • Candriam SCA's ten largest holdings make up 21% of its $9.02B portfolio in Q1 2020.
  • Candriam SCA opened 30 new positions and closed 20 in Q1 2020.
  • Candriam SCA's portfolio value fell 3.3% quarter-over-quarter to $9.02B.

Based on Candriam SCA's 13F filing for Q1 2020, filed 26 May 2020.